Stock Analysis
Oscar Health, Inc. (OSCR) Stock Analysis
Oscar Health, Inc. (OSCR) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Oscar Health, Inc. (OSCR) currently has an AIQ Score of 64/100, indicating a neutral setup. Quality is the strongest factor at 86/100. Risk is the weakest current factor at 29/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
OSCR at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $32.77 |
| AIQ Score | 64/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $7.73B |
| P/E Ratio | 21.31 |
| Forward P/E | — |
| EPS | $1.20 |
| Revenue TTM | $4.88B |
| Dividend Yield | 0.00% |
| Beta | 2.39 |
| Volume | 7.1M |
| 52-week range | $10.69-$34.23 |
| RSI 14 | 54.01 |
| 50-Day SMA | $30.61 |
| 200-Day SMA | $20.86 |
| Analyst Price Target | $27.64 |
| Next Earnings | Nov 9, 2026 |
OSCR
OverviewOSCR Stock Analysis Summary
Oscar Health, Inc. (OSCR) currently has an AIQ Score of 64/100, indicating a neutral setup. Quality is the strongest factor at 86/100. Risk resilience is the weakest current factor at 29/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, OSCR has AIQ Score of 64/100 with Quality base of 86/100 and fading Risk resilience at 29/100. Wait for component alignment before adding exposure.
Quality (86/100) leads while Risk resilience (29/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · 0.58% stock move · OSCR classified in Medical - Healthcare Plans.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is OSCR Bullish or Bearish Right Now?
OSCR currently has a neutral overall setup. Quality is the strongest factor at 86/100, while Risk Resilience is weakest at 29/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Quality is supportive at 86/100.
- - Momentum is constructive at 65/100.
- - Price is +7.04% above its 50-day SMA.
- - Technical consensus has more buy votes than sell votes (35 vs 4).
- - Risk Resilience is weak at 29/100.
- - Analyst target implies -15.65% downside from the latest quote.
Current Consensus
OSCR's Technical Analysis Consensus is currently Strong Buy, with 35 buy, 6 neutral, and 4 sell votes. OSCR's 14-day RSI is 54.01, which places the stock in a neutral momentum range. OSCR's beta is 2.39, indicating greater market sensitivity than the broad market.
What Changed in OSCR?
Recent score-change history is not available in the current snapshot. These are the latest market-close scores instead.
What Would Change the OSCR Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
OSCR Decision Framework
Public evidence layers, setup checks, and risk context for Oscar Health, Inc..
Oscar Health, Inc. (OSCR) Stock Analysis
Oscar Health, Inc. has an AIQ Score of 64/100 in a Neutral regime. Quality is strongest at 86/100. Beta is 2.39, above market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | OSCR is in a Neutral AIQ regime with score 64/100. |
| Signal Conflict | The primary conflict is that quality leads at 86/100 while risk lags at 29/100. |
| Factor Evidence | Momentum 65/100 · Value 59/100 · Quality 86/100 · Risk 29/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Quality is the strongest factor at 86/100.
Momentum is 65/100 and RSI (14) is 54.0.
OSCR is in a Neutral regime at 64/100.
Risk factor is 29/100 with beta 2.39 and annual volatility 70.62%.
Current conflict: quality leads at 86/100 while risk lags at 29/100.
OSCR Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
OSCR Fundamentals
OSCR valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
OSCR Technical Analysis
OSCR technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
OSCR Stock Catalysts
Track OSCR earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
OSCR Dividend Analysis
OSCR dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
OSCR Financial Data
OSCR revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
OSCR Risk Analysis
OSCR volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
OSCR Stock News
OSCR stock news, market tone, recent headlines, and catalyst context.
OSCR vs Healthcare Services / Managed Care Peers
Current peer cohort: OSCR · PGNY · PHR · PRVA · TDOC. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| OSCR Current stock | 64/100 | 59/100 | 65/100 | 29/100 | 1.03 | 70.62% | Current |
| PGNY Progyny | 58/100 | 51/100 | 62/100 | 70/100 | 0.54 | 55.25% | OSCR vs PGNY |
| PHR Phreesia | 44/100 | 42/100 | 24/100 | 50/100 | -1.29 | 58.56% | OSCR vs PHR |
| PRVA Privia Health | 40/100 | 42/100 | 26/100 | 72/100 | -0.3 | 31.88% | OSCR vs PRVA |
| TDOC Teladoc Health | 47/100 | 65/100 | 35/100 | 27/100 | -0.03 | 64.39% | OSCR vs TDOC |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Sep 11, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts8 recent quarterly periods are available for review.
Checked Sep 12, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching OSCR
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for OSCR
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
OSCR Stock FAQ
What is OSCR stock price today?
Oscar Health, Inc.'s current stock price is $32.77. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is OSCR bullish or bearish right now?
OSCR's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is OSCR's market cap?
OSCR's market cap is $7.73B based on the latest completed market-close snapshot from Sep 11, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is OSCR's current P/E ratio?
OSCR's current P/E ratio is 21.31 based on the latest completed market-close snapshot from Sep 11, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is OSCR's RSI?
OSCR's 14-day RSI is 54.01 based on the latest completed market-close snapshot from Sep 11, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is OSCR above its 50-day and 200-day moving averages?
OSCR is 7.04% from its 50-day SMA and 57.08% from its 200-day SMA based on the latest completed market-close snapshot from Sep 11, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is OSCR's next earnings date?
OSCR's next earnings date is currently listed as Nov 9, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does OSCR pay a dividend?
OSCR's dividend yield is 0.00% based on the latest completed market-close snapshot from Sep 11, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.